Evaluation of the intervention effect of positive emotion regulation on chronic stress in patients with lung cancer undergoing immunotherapy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500101887

Enrollment

Unknown

Registered

2025-04-30

Start date

2025-04-30

Completion date

Unknown

Last updated

2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Intervention group:Usual care Positive emotion regulation interventions

Control group:Usual care

Eligibility

Sex/Gender

All

Age

18 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Age>=18 years old; 2. Pathologic diagnosis of lung cancer; 3. Diagnosis time>=1 month; 4. Perceived Stress Questionnaire (PSS) score>= 29 points; 5. Receiving immunotherapy, monotherapy or combination therapy; 6. Know your own condition; 7. Those who have informed consent to participate in this study and can communicate normally; 8. Patients can and do use electronic devices.

Exclusion criteria

Exclusion criteria: 1. Autoimmune diseases requiring immunosuppressive therapy; 2. Patients with other cancers or serious life-threatening diseases; 3. Those with impaired consciousness; 4. Participate in other psychosocial research projects at the same time; 5. Currently receiving psychiatric or psychological treatment.

Design outcomes

Primary

Measure	Time frame
Chronic stress levels;Unsteady state load;	—

Secondary

Measure	Time frame
Ways to cope with cancer;Disease cognition;Symptom assessment in patients with lung cancer;Quality of life in lung cancer patients;Positive emotions;Tumor markers;	—

Countries

China

Contacts

Public ContactTeng Liping

Jiangnan University Hospital; Jiangnan University

teliping@jiangnan.edu.cn+86 159 5158 1260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026